Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [ 18 f]fdg pet. bokenmeyer c., kollmannsberger c., oechsle k., et al. - British journal of cancer (2002) 86:506-511

Author： Rowland R.G.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.1, 2003-01, pp. : 88-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support

By Kollmannsberger C.   Schleucher N.   Rick O.   Metzner B.   Hartmann J.T.   Schoffski P.   Beyer J.   Casper J.   Sosada M.   Schmoll H.-J.   Bohlke I.   Meisner C.   Kanz L.   Bokemeyer C.  

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 775-782

Elsevier

Access to resources Recommend Favorite

Early colon cancer detected by 18 F-FDG PET

By Sakamoto Kazuhiro  

International Journal of Gastrointestinal Cancer, Vol. 36, Iss. 2, 2005-10 ,pp. : 95-98

Humana Press, Inc

Access to resources Recommend Favorite

Early Assessment of Axillary Response with 18F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla

By Koolen Bas   Valdés Olmos Renato   Wesseling Jelle   Vogel Wouter   Vincent Andrew   Gilhuijs Kenneth   Rodenhuis Sjoerd   Rutgers Emiel   Vrancken Peeters Marie-Jeanne  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2227-2235

Springer Publishing Company

Access to resources Recommend Favorite

Determinants of Response to Neoadjuvant Chemotherapy for Esophageal Cancer Using 18F-fluorodeoxiglucose Positron Emission Tomography (18F-FDG-PET)

By Miyata Hiroshi   Yamasaki Makoto   Takahashi Tsuyoshi   Murakami Kohei   Tanaka Koji   Yukinori Kurokawa   Nakajima Kiyokazu   Takiguchi Shuji   Morii Eiichi   Hatazawa Jun   Mori Masaki   Doki Yuichiro  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 575-582

Springer Publishing Company

Access to resources Recommend Favorite

Reply to “Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, but not CK18: Comment on ‘Early Assessment of Axillary Response with 18F-FDG PET/CT During Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla. Ann Surg Oncol. 2013;20(7):2227–35’”

By Koolen Bas   Wesseling Jelle  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 700-700

Springer Publishing Company

Access to resources Recommend Favorite